{
    "title": "Bayer, J&J win first trial over Xarelto bleeding risks",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4471278/Bayer-J-J-win-trial-Xarelto-bleeding-risks.html",
    "date": "2017-05-03",
    "keywords": [
        "verdict",
        "xarelto",
        "bayer",
        "trial",
        "blood",
        "raymond",
        "jury",
        "johnson",
        "liability",
        "lawsuit",
        "boudreaux",
        "test",
        "information",
        "statement",
        "litigation",
        "drug",
        "heart",
        "risk",
        "bleeding",
        "case",
        "district",
        "ag",
        "thinner",
        "joseph",
        "louisiana",
        "series",
        "jurys",
        "safety",
        "efficacy",
        "label",
        "medicine",
        "william",
        "spokesman",
        "jampjs",
        "janssen",
        "unit",
        "appropriateness",
        "birchfield",
        "barr",
        "experience",
        "state",
        "food",
        "administration",
        "rhythm",
        "disorder",
        "fibrillation",
        "vein",
        "thrombosis",
        "jampj",
        "boudreauxs",
        "condition",
        "hospitalization",
        "class",
        "coumadin",
        "warfarin",
        "market",
        "subject",
        "boehringer",
        "settlement",
        "court",
        "reporting",
        "boston",
        "editing",
        "jonathan",
        "oatis",
        "lisa",
        "shumaker"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}